Aarti Pharmalabs Ltd.

Aarti Pharmalabs has informed that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024, to consider and approve Audited Financial Results for the quarter ended March 31, 2024; Audited Financial Statements for the year ended March 31, 2024; Recommend Final Dividend, if any, for the year ended March 31, 2024; Approve any other business matter, if required, with the permission of Chair. 

The above information is a part of company’s filings submitted to BSE.